Funder: Agency for Healthcare Research and Quality (AHRQ)
Due Dates: October 16, 2024 (First application) | August 1, 2026 (Expiration)
Funding Amounts: Up to $280,000 total for R21 phase (max 2 years); up to $720,000 total for R33 phase (max 3 years); total project period up to 5 years.
Summary: Supports phased research projects testing innovative digital healthcare interventions at the point of care to improve healthcare quality, with optional clinical trials.
Key Information: Uses Phased Innovation Award (R21/R33) mechanism; transition to R33 phase contingent on milestone achievement and funding availability; clinical trial optional.